RU2013155894A - METHOD FOR PRODUCING FIBRINOGEN CONCENTRATE - Google Patents
METHOD FOR PRODUCING FIBRINOGEN CONCENTRATE Download PDFInfo
- Publication number
- RU2013155894A RU2013155894A RU2013155894/10A RU2013155894A RU2013155894A RU 2013155894 A RU2013155894 A RU 2013155894A RU 2013155894/10 A RU2013155894/10 A RU 2013155894/10A RU 2013155894 A RU2013155894 A RU 2013155894A RU 2013155894 A RU2013155894 A RU 2013155894A
- Authority
- RU
- Russia
- Prior art keywords
- inactivation
- virus
- purification
- reagents
- products
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ выделения очищенного концентрата фибриногена, избавленного от вирусов, заключающийся в солюбилизации исходного сырья, представленного криопреципитатом свежезамороженной плазмы человека, осаждении ПЭГом, вирусной инактивации сольвент-детергентным методом, используя в качестве реагентов вирусной инактивации 1-3% Tween-80 и 0,1-1,5% TnBP, очистке получившегося концентрата от продуктов вирусной инактивации и сольвент-детергентов, последующем переосаждении 1-2,5 М глицином, стерильной фильтрации и лиофильном высушивании с последующим укупориванием под вакуумом и термоинактивацией, отличающийся тем, что в качестве метода очистки концентрата фибриногена от продуктов и реагентов процесса вирусной инактивации используют метод экстракции раствора вазелиновым маслом, процедуру экстракции проводят трехкратно.The method of isolation of the purified virus-free fibrinogen concentrate, which consists in solubilizing the feedstock represented by cryoprecipitate of freshly frozen human plasma, PEG precipitation, virus inactivation by the solvent-detergent method, using 1-3% Tween-80 and 0.1- as viral inactivation reagents 1.5% TnBP, purification of the resulting concentrate from viral inactivation products and solvent detergents, subsequent reprecipitation of 1-2.5 M glycine, sterile filtration and freeze drying, followed by capping by vacuum and thermal inactivation, characterized in that as a method of purification of fibrinogen concentrate from products and reagents of the virus inactivation process, the solution is extracted with liquid paraffin, the extraction procedure is carried out three times.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013155894/10A RU2556804C2 (en) | 2013-12-17 | 2013-12-17 | Method of obtaining fibrinogen concentrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013155894/10A RU2556804C2 (en) | 2013-12-17 | 2013-12-17 | Method of obtaining fibrinogen concentrate |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013155894A true RU2013155894A (en) | 2015-06-27 |
RU2556804C2 RU2556804C2 (en) | 2015-07-20 |
Family
ID=53497045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013155894/10A RU2556804C2 (en) | 2013-12-17 | 2013-12-17 | Method of obtaining fibrinogen concentrate |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2556804C2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2916711A1 (en) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blood coagulation factors and process for their manufacture |
DE3230849A1 (en) * | 1982-08-19 | 1984-02-23 | Behringwerke Ag, 3550 Marburg | PASTEURIZED HUMAN FIBRINOGEN (HF) AND METHOD FOR THE PRODUCTION THEREOF |
US4789545A (en) * | 1986-03-31 | 1988-12-06 | New York Blood Center, Inc. | Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof |
RU2062103C1 (en) * | 1994-09-29 | 1996-06-20 | Московская медицинская академия им.И.М.Сеченова | Method of fibrinogen concentrate preparing |
RU2158130C1 (en) * | 1999-12-17 | 2000-10-27 | Нижегородское государственное предприятие по производству бактерийных препаратов фирма "ИмБио" | Method of fibrinogen producing |
US9371355B2 (en) * | 2010-09-20 | 2016-06-21 | Octapharma Ag | Process for production of fibrinogen |
-
2013
- 2013-12-17 RU RU2013155894/10A patent/RU2556804C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2556804C2 (en) | 2015-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20130186B1 (en) | Purification of virus like particles | |
CO2017005371A2 (en) | System for the preparation of platelet-rich plasma, bone marrow concentrate, a composition and its method of obtaining | |
EA201791776A1 (en) | SUBSTITUTED CYCLOPHANES FOR USE WHEN TREATING HCV INFECTION | |
EA201391152A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
AR090473A1 (en) | NON-VIABLE MATERIAL DERIVED FROM PROBIOTICS SUITABLE FOR THE PREVENTION AND TREATMENT OF INFECTION, COMPOSITION | |
EA201391170A1 (en) | THERAPEUTIC MEANS BASED ON YEAST FOR THE TREATMENT OF CHRONIC HEPATITIS B | |
EA201490654A1 (en) | NEW INHIBITORS OF VIRAL REPLICATION | |
EA201390806A1 (en) | CONSTRUCTION OF PEPTIDE FRAME | |
EA201370017A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201391685A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
PE20141264A1 (en) | PROCEDURE FOR OBTAINING A COMPOSITION CONTAINING GROWTH FACTORS FROM A BLOOD COMPOUND, AND COMPOSITION OBTAINABLE BY SUCH PROCEDURE | |
NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
BR112018073572A2 (en) | caffeine adsorption material, caffeine adsorption system, decaffeination system and related methods of caffeine removal from solutions | |
MX2022002639A (en) | System and method to efficiently clean a blood filter. | |
CL2016002442A1 (en) | Rnasa for use in the treatment or prevention of viral infections. | |
EA201691563A1 (en) | DRY ACID CONCENTRATE IN GRANULATED FORM | |
EA201592298A1 (en) | HUMAN VIRAL VACCINE AGAINST THE RESPIRATORY SYNCTIAL VIRUS | |
RU2013155894A (en) | METHOD FOR PRODUCING FIBRINOGEN CONCENTRATE | |
MX2015016670A (en) | Process for preparing apolipoprotein a-i (apo a-i). | |
EA201790778A1 (en) | PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FROM HEPATITIS C | |
BR112017014583A2 (en) | method for fractionation of components of a protein rich microalgae biomass | |
EA201790776A1 (en) | COMBINED COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS OF TREATING HEPATITIS C | |
EA201592299A1 (en) | HUMAN VIRAL VACCINE AGAINST THE RESPIRATORY SYNCTIAL VIRUS | |
EA201791966A1 (en) | EXTRACTION AND CONCENTRATION OF FOOD FLAVORING SUBSTANCES | |
RU2014123185A (en) | METHOD FOR PRODUCING A VIRUS-FREE ACTIVATED THROMBINE COMPLEX POSSESSING THE VIII-BYPASS ACTIVITY FACTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH4A | Copy of patent granted that was duplicated for the russian federation |
Effective date: 20200901 |